These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2564436)

  • 1. Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
    Rao JM; Cowie VA; Mathew B
    J Ment Defic Res; 1989 Feb; 33 ( Pt 1)():81-6. PubMed ID: 2564436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia in neuroleptic medicated mentally handicapped subjects.
    Rao JM; Cowie VA; Mathew B
    Acta Psychiatr Scand; 1987 Nov; 76(5):507-13. PubMed ID: 2893512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akathisia in neuroleptic medicated mentally handicapped subjects.
    Ganesh S; Murti Rao JM; Cowie VA
    J Ment Defic Res; 1989 Aug; 33 ( Pt 4)():323-9. PubMed ID: 2570159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskinesia in mentally handicapped women: relationship to level of handicap, age and neuroleptic exposure.
    Farren CK; Dinan TG
    Acta Psychiatr Scand; 1994 Sep; 90(3):210-3. PubMed ID: 7810345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA; Haugland G; Craig TJ
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia in young mentally retarded individuals.
    Gualtieri CT; Schroeder SR; Hicks RE; Quade D
    Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE; Povlsen UJ; Meidahl B; Gerlach J
    Psychopharmacol Bull; 1986; 22(1):250-3. PubMed ID: 2873612
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics.
    Youssef HA; Waddington JL
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):863-5. PubMed ID: 2900294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia.
    Elliott KJ; Lewis S; el-Mallakh RS; Looney SW; Caudill R; Bacani-Oropilla T
    Ann Clin Psychiatry; 1994 Sep; 6(3):197-203. PubMed ID: 7881501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "neuroleptic" antipsychotic drugs. 2. Neurologic side effects.
    Baldessarini RJ
    Postgrad Med; 1979 Apr; 65(4):123-8. PubMed ID: 34142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal aspects of neuroleptic-induced movement disorders.
    Wettstein RM
    Leg Med; 1985; ():117-79. PubMed ID: 2872562
    [No Abstract]   [Full Text] [Related]  

  • 18. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
    Ganzini L; Heintz R; Hoffman WF; Keepers GA; Casey DE
    J Geriatr Psychiatry Neurol; 1991; 4(4):222-5. PubMed ID: 1686396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.
    Bocola V; Fabbrini G; Sollecito A; Paladini C; Martucci N
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):213-6. PubMed ID: 8708659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.